High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

Rischin, Danny ; Hughes, Brett G M ; Basset-Séguin, Nicole ; Schadendorf, Dirk ; Bowyer, Samantha ; Trabelsi Messai, Sabiha ; Meier, Friedegund ; Eigentler, Thomas K ; Casado Echarren, Victoria ; Stein, Brian ; Beylot-Barry, Marie ; Dalac, Sophie ; Dréno, Brigitte ; Migden, Michael R ; Hauschild, Axel ; Schmults, Chrysalyne D ; Lim, Annette M ; Yoo, Suk-Young ; Paccaly, Anne J ; Papachristos, Apostolos ; Nguyen, Jenny-Hoa ; Okoye, Emmanuel ; Seebach, Frank ; Booth, Jocelyn ; Lowy, Israel ; Fury, Matthew G ; Guminski, Alexander

England: BMJ Publishing Group Ltd

Texto completo disponível

535 A phase I/II study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors

Lakhani, Nehal ; Johnson, Melissa ; Groisberg, Roman ; Han, Hyunsil ; Casey, Kerry ; Li, Siyu ; Skokos, Dimitris ; Seebach, Frank ; Lowy, Israel ; Fury, Matthew ; Mathias, Melissa

London: BMJ Publishing Group Ltd

Texto completo disponível

A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer

Kelly, William Kevin ; Hussain, Arif ; Saraiya, Biren ; Thanigaimani, Pradeep ; Sun, Furong ; Seebach, Frank A. ; Lowy, Israel ; Sandigursky, Sabina ; Miller, Elizabeth

Texto completo disponível

A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer

Kelly, William Kevin ; Thanigaimani, Pradeep ; Sun, Furong ; Seebach, Frank A. ; Lowy, Israel ; Sandigursky, Sabina ; Miller, Elizabeth

Texto completo disponível

A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: Trial-in-progress update

Segal, Neil Howard ; Pelster, Meredith ; Girda, Eugenia ; Fong, Lawrence ; Olszanski, Anthony J. ; Han, Hyunsil ; Casey, Kerry A. ; Li, Siyu ; Welf, Erik ; Chen, Chieh-I ; Skokos, Dimitris ; Seebach, Frank A. ; Lowy, Israel ; Fury, Matthew G. ; Mathias, Melissa Divya ; Lakhani, Nehal J.

Texto completo disponível

A phase 1/2 study of REGN5093-M114, a METxMET antibody-drug conjugate, in patients with mesenchymal epithelial transition factor (MET)-overexpressing NSCLC

Drilon, Alexander E. ; Awad, Mark M. ; Gadgeel, Shirish M. ; Villaruz, Liza C ; Sabari, Joshua K. ; Perez, Javier ; Daly, Christopher ; Patel, Shraddha ; Li, Siyu ; Seebach, Frank A. ; Lowy, Israel ; Magnan, Heather D. ; Rietschel, Petra

Texto completo disponível

428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs)

Lewis, Karl ; Peris, Ketty ; Sekulic, Aleksandar ; Stratigos, Alexander ; Dunn, Lara ; Eroglu, Zeynep ; Chang, Anne Lynn ; Migden, Michael ; Li, Siyu ; Mohan, Kosalai ; Coates, Ebony ; Okoye, Emmanuel ; Baurain, Jean-François ; Bechter, Oliver ; Hauschild, Axel ; Butler, Marcus ; Hernandez-Aya, Leonel ; Licitra, Lisa ; Neves, Rogerio ; Ruiz, Emily ; Seebach, Frank ; Weinreich, David ; Yancopoulos, George ; Lowy, Israel ; Bowler, Timothy ; Fury, Matthew

London: BMJ Publishing Group LTD

Texto completo disponível

Phase II trial of Voyager-V1 (vesicular stomatitis virus expressing human IFNβ and NIS, VV1), in combination with cemiplimab (C) in patients with NSCLC, melanoma, HCC or endometrial carcinoma

Sznol, Mario ; Lutzky, Jose ; Adjei, Alex A. ; Powell, Steven Francis ; He, Aiwu Ruth ; Patel, Manish ; O'Day, Steven ; Pandya, Naimish B. ; Kaesshaefer, Stephen ; Reckner, Monica ; Brown, Cheryl ; Diaz, Rosa M ; Russell, Luke ; Peng, Kah Whye ; Wiegert, Erol ; Gullo, Giuseppe ; Seebach, Frank A. ; Lowy, Israel ; Bexon, Alice Susannah

Texto completo disponível

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Migden, Michael R ; Rischin, Danny ; Schmults, Chrysalyne D ; Guminski, Alexander ; Hauschild, Axel ; Lewis, Karl D ; Chung, Christine H ; Hernandez-Aya, Leonel ; Lim, Annette M ; Chang, Anne Lynn S ; Rabinowits, Guilherme ; Thai, Alesha A ; Dunn, Lara A ; Hughes, Brett G.M ; Khushalani, Nikhil I ; Modi, Badri ; Schadendorf, Dirk ; Gao, Bo ; Seebach, Frank ; Li, Siyu ; Li, Jingjin ; Mathias, Melissa ; Booth, Jocelyn ; Mohan, Kosalai ; Stankevich, Elizabeth ; Babiker, Hani M ; Brana, Irene ; Gil-Martin, Marta ; Homsi, Jade ; Johnson, Melissa L ; Moreno, Victor ; Niu, Jiaxin ; Owonikoko, Taofeek K ; Papadopoulos, Kyriakos P ; Yancopoulos, George D ; Lowy, Israel ; Fury, Matthew G

United States: Massachusetts Medical Society

Texto completo disponível

Survival with Cemiplimab in Recurrent Cervical Cancer

Tewari, Krishnansu S ; Monk, Bradley J ; Vergote, Ignace ; Miller, Austin ; de Melo, Andreia C ; Kim, Hee-Seung ; Kim, Yong Man ; Lisyanskaya, Alla ; Samouëlian, Vanessa ; Lorusso, Domenica ; Damian, Fernanda ; Chang, Chih-Long ; Gotovkin, Evgeniy A ; Takahashi, Shunji ; Ramone, Daniella ; Pikiel, Joanna ; Maćkowiak-Matejczyk, Beata ; Guerra Alía, Eva M ; Colombo, Nicoletta ; Makarova, Yulia ; Rischin, Danny ; Lheureux, Stephanie ; Hasegawa, Kosei ; Fujiwara, Keiichi ; Li, Jingjin ; Jamil, Shaheda ; Jankovic, Vladimir ; Chen, Chieh-I ; Seebach, Frank ; Weinreich, David M ; Yancopoulos, George D ; Lowy, Israel ; Mathias, Melissa ; Fury, Matthew G ; Oaknin, Ana

United States: Massachusetts Medical Society

Texto completo disponível